Bath & Body Works (NYSE:BBWI) Price Target Raised to $34.00

Bath & Body Works (NYSE:BBWI) had its price target upped by research analysts at Barclays from $28.00 to $34.00 in a research report issued on Tuesday,Benzinga reports. The brokerage presently has an “underweight” rating on the stock. Barclays‘s target price would suggest a potential downside of 4.97% from the company’s previous close.

Other equities analysts have also recently issued research reports about the company. Robert W. Baird reduced their target price on Bath & Body Works from $54.00 to $45.00 and set an “outperform” rating for the company in a report on Thursday, August 29th. Raymond James decreased their price objective on Bath & Body Works from $51.00 to $42.00 and set an “outperform” rating on the stock in a report on Thursday, August 29th. Evercore ISI dropped their target price on shares of Bath & Body Works from $45.00 to $35.00 and set an “in-line” rating for the company in a report on Wednesday, August 28th. BMO Capital Markets reiterated an “outperform” rating and issued a $50.00 target price (down from $52.00) on shares of Bath & Body Works in a research report on Thursday, August 29th. Finally, The Goldman Sachs Group lowered their price target on shares of Bath & Body Works from $60.00 to $49.00 and set a “buy” rating on the stock in a research report on Thursday, August 29th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and nine have given a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $42.44.

Bath & Body Works Stock Performance

Bath & Body Works stock opened at $35.78 on Tuesday. The stock has a market capitalization of $7.84 billion, a P/E ratio of 8.66, a P/E/G ratio of 0.98 and a beta of 1.79. The company’s fifty day moving average price is $30.69 and its 200 day moving average price is $35.74. Bath & Body Works has a 1 year low of $26.20 and a 1 year high of $52.99.

Bath & Body Works (NYSE:BBWI) last announced its earnings results on Wednesday, August 28th. The company reported $0.37 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.35 by $0.02. Bath & Body Works had a net margin of 12.69% and a negative return on equity of 41.94%. The business had revenue of $1.53 billion for the quarter, compared to analyst estimates of $1.54 billion. Sell-side analysts predict that Bath & Body Works will post 3.18 EPS for the current year.

Insider Buying and Selling at Bath & Body Works

In other Bath & Body Works news, CEO Gina Boswell acquired 6,000 shares of the business’s stock in a transaction that occurred on Wednesday, October 9th. The stock was purchased at an average cost of $29.64 per share, with a total value of $177,840.00. Following the transaction, the chief executive officer now owns 242,987 shares of the company’s stock, valued at $7,202,134.68. This trade represents a 2.53 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Company insiders own 0.27% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the stock. CWM LLC increased its holdings in Bath & Body Works by 6.6% in the 2nd quarter. CWM LLC now owns 5,072 shares of the company’s stock valued at $198,000 after purchasing an additional 314 shares during the last quarter. Northwest Bank & Trust Co lifted its stake in Bath & Body Works by 2.5% during the 1st quarter. Northwest Bank & Trust Co now owns 13,094 shares of the company’s stock worth $655,000 after acquiring an additional 315 shares in the last quarter. DekaBank Deutsche Girozentrale grew its position in Bath & Body Works by 1.0% in the 1st quarter. DekaBank Deutsche Girozentrale now owns 31,797 shares of the company’s stock valued at $1,560,000 after acquiring an additional 322 shares in the last quarter. TD Private Client Wealth LLC lifted its position in shares of Bath & Body Works by 24.2% during the third quarter. TD Private Client Wealth LLC now owns 1,697 shares of the company’s stock worth $54,000 after purchasing an additional 331 shares in the last quarter. Finally, Citizens & Northern Corp grew its holdings in shares of Bath & Body Works by 1.7% in the second quarter. Citizens & Northern Corp now owns 29,465 shares of the company’s stock valued at $1,151,000 after purchasing an additional 487 shares in the last quarter. Hedge funds and other institutional investors own 95.14% of the company’s stock.

Bath & Body Works Company Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.